Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 11262023Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Biomedical Engineering
- Biochemistry
NIH Funding · FY2024
Linked Award Amount
$1.2M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#11,991
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Jonathan F Lovell as a PI. Multi-PI records show the full award amount for context.
- 5R61AI169199-03R61Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis$453Kaward amount
- 5R01AI148557-05R01Rationally-Designed, Spontaneous-Particleized Pfs48/45 for a Multivalent Malaria Vaccine$392Kaward amount
- 5R01CA247771-05R01A Cobalt Porphyrin Nanoliposome Adjuvant for MHC-I-Restricted Cancer Peptide Vaccines$359.5Kaward amount
Award organization
Organizations that administered FY2024 awards listing Jonathan F Lovell as a PI.
FY2024 award administered by University at Buffalo (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity at Buffalo
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2025$2M Cumulative Funding
- 2025Entered Top 50% NationallyRanked #8984
- 2025R01 Grant Holder
- 2026Entered Top 25% NationallyRanked #4888
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Jonathan F Lovell.